Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 196
Filter
1.
J Endocrinol Invest ; 45(10): 1865-1874, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35635644

ABSTRACT

PURPOSE: After a recommendation for iodine supplementation in pregnancy has been issued in 2013 in Portugal, there were no studies covering iodine status in pregnancy in the country. The aim of this study was to assess iodine status in pregnant women in Porto region and its association with iodine supplementation. METHODS: A cross-sectional study was conducted at Centro Hospitalar Universitário São João, Porto, from April 2018 to April 2019. Pregnant women attending the 1st trimester ultrasound scan were invited to participate. Exclusion criteria were levothyroxine use, gestational age < 10 and ≥ 14 weeks, non-evolutive pregnancy at recruitment and non-signing of informed consent. Urinary iodine concentration (UIC) was measured in random spot urine by inductively coupled plasma-mass spectrometry. RESULTS: Median UIC was 104 µg/L (IQR 62-189) in the overall population (n = 481) of which 19% had UIC < 50 µg/L. Forty three percent (n = 206) were not taking an iodine-containing supplement (ICS) and median UIC values were 146 µg/L (IQR 81-260) and 74 µg/L (IQR 42-113) in ICS users and non-users, respectively (p < 0.001). Not using an ICS was an independent risk factor for iodine insufficiency [adjusted OR (95% CI) = 6.00 (2.74, 13.16); p < 0.001]. Iodised salt use was associated with increased median iodine-to-creatinine ratio (p < 0.014). CONCLUSIONS: A low compliance to iodine supplementation recommendation in pregnancy accounted for a mild-to-moderately iodine deficiency. Our results evidence the need to support iodine supplementation among pregnant women in countries with low household coverage of iodised salt. Trial registration number NCT04010708, registered on the 8th July 2019.


Subject(s)
Iodine , Pregnant Women , Cross-Sectional Studies , Dietary Supplements , Female , Humans , Infant , Nutritional Status , Portugal/epidemiology , Pregnancy , Risk Factors , Sodium Chloride, Dietary
2.
Ir Med J ; 113(7): 119, 2020 Jul 30.
Article in English | MEDLINE | ID: mdl-35574822

ABSTRACT

Aims Our aim was to assess if outcomes for cystic fibrosis (CF) patients at six & sixteen years of age have improved in the last 17 years looking at FEV1, BMI and death. Methods A retrospective observational study using a prospectively maintained database of CF patients at Cork University Hospital. Results 84 patients were included in the 16-year-old data and 89 patients were included in the six-year-old data. The mean FEV1 and BMI (16 years) for the 2002-2007 group was 72.9±21.0% and 18.9±2.53 respectively, 2008-2013 group was 75.4±27.2% and 19.8±2.7 and for the 2014-2018 group was 95.2±16.0% and 22.9±4.1. The percentage of patients (16 years) with chronic pseudomonas status was 37.9% (11/30) in the 2002-2007 group, 51.6 % (16/31) in the 2008-2013 group and 4.2% (1/24) in the 2014-2018 group. The relationship between FEV1 and FVC with BMI remained significant in multivariate analysis (P <0.001). The mean FEV1 (six years) for the 2002-2007 group was 90.7±16.1%, 2008-2013 group was 99.3±17.9% and for the 2014-2018 group was 100.9±15.8%. Conclusions Improvements in FEV1 and BMI aged six and 16 years are notable as well as a significant decline in the number of patients with chronic pseudomonas.

3.
Int J Cardiol ; 278: 114-119, 2019 Mar 01.
Article in English | MEDLINE | ID: mdl-30391065

ABSTRACT

BACKGROUND: Low voltage zones (LVZs) are associated with conduction velocity (CV) slowing. Rate-dependent CV slowing may play a role in reentry mechanisms. METHODS: Patients undergoing catheter ablation for AT were enrolled. Aim was to assess the relationship between rate-dependent CV slowing and sites of localized reentrant atrial tachycardias (AT). On a bipolar voltage map regions were defined as non-LVZs [≥0.5 mV], LVZs [0.2-0.5 mV] and very-LVZs [<0.2 mV]. Unipolar electrograms were recorded with a 64-pole basket catheter during uninterrupted atrial pacing at four pacing intervals (PIs) during sinus rhythm. CVs were measured between pole pairs along the wavefront path. Sites of rate-dependent CV slowing were defined as exhibiting a reduction in CV between PI = 600 ms and 250 ms of ≥20% more than the mean CV reduction seen between these PIs for that voltage zone. Rate-dependent CV slowing sites were correlated to sites of localized reentrant ATs as confirmed with conventional mapping, entrainment and response to ablation. RESULTS: Eighteen patients were included (63 ±â€¯10 years). Mean CV at 600 ms was 1.53 ±â€¯0.19 m/s in non-LVZs, 1.14 ±â€¯0.15 m/s in LVZs, and 0.73 ±â€¯0.13 m/s in very-LVZs respectively (p < 0.001). Rate-dependent CV slowing sites were predominantly in LVZs [0.2-0.5 mV] (74.4 ±â€¯10.3%; p < 0.001). Localized reentrant ATs were mapped to these sites in 81.8% of cases (sensitivity 81.8%, 95% CI 48.2-97.9% and specificity 83.9%, 95% CI 81.8-86.0%). Macro-reentrant or focal ATs were not mapped to sites of rate-dependent CV slowing. CONCLUSIONS: Rate-dependent CV slowing sites are predominantly confined to LVZs [0.2-0.5 mV] and the resultant CV heterogeneity may promote reentry mechanisms. These may represent a novel adjunctive target for AT ablation.


Subject(s)
Atrial Fibrillation/physiopathology , Catheter Ablation/methods , Heart Atria/physiopathology , Heart Conduction System/physiopathology , Heart Rate/physiology , Aged , Atrial Fibrillation/diagnostic imaging , Atrial Fibrillation/surgery , Catheter Ablation/trends , Female , Heart Atria/diagnostic imaging , Heart Conduction System/diagnostic imaging , Heart Conduction System/surgery , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies
4.
J Cardiovasc Electrophysiol ; 29(3): 395-403, 2018 03.
Article in English | MEDLINE | ID: mdl-29364554

ABSTRACT

INTRODUCTION: This study sought to validate a novel wavefront mapping system utilizing whole-chamber basket catheters (CARTOFINDER, Biosense Webster). The system was validated in terms of (1) mapping atrial-paced beats and (2) mapping complex wavefront patterns in atrial tachycardia (AT). METHODS AND RESULTS: Patients undergoing catheter ablation for AT and persistent AF were included. A 64-pole-basket catheter was used to acquire unipolar signals that were processed by CARTOFINDER mapping system to generate dynamic wavefront propagation maps. The left atrium was paced from four sites to demonstrate focal activation. ATs were mapped with the mechanism confirmed by conventional mapping, entrainment, and response to ablation. Twenty-two patients were included in the study (16 with AT and 6 with AF initially who terminated to AT during ablation). In total, 172 maps were created with the mapping system. It correctly identified atrial-pacing sites in all paced maps. It accurately mapped 9 focal/microreentrant and 18 macroreentrant ATs both in the left and right atrium. A third and fourth observer independently identified the sites of atrial pacing and the AT mechanism from the CARTOFINDER maps, while being blinded to the conventional activation maps. CONCLUSIONS: This novel mapping system was effectively validated by mapping focal activation patterns from atrial-paced beats. The system was also effective in mapping complex wavefront patterns in a range of ATs in patients with scarred atria. The system may therefore be of practical use in the mapping and ablation of AT and could have potential for mapping wavefront activations in AF.


Subject(s)
Action Potentials , Electrophysiologic Techniques, Cardiac , Tachycardia, Supraventricular/diagnosis , Aged , Cardiac Catheters , Cardiac Pacing, Artificial , Catheter Ablation , Electrophysiologic Techniques, Cardiac/instrumentation , Female , Heart Rate , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Tachycardia, Supraventricular/physiopathology , Tachycardia, Supraventricular/surgery , Treatment Outcome
5.
J Arthroplasty ; 31(10): 2199-202, 2016 10.
Article in English | MEDLINE | ID: mdl-27430182

ABSTRACT

BACKGROUND: Total knee arthroplasty (TKA) has been shown to be very successful with long-term follow-ups. But there are no reports showing prosthesis survival at 25-30 years. Here, we report the outcomes for 25-30 years using the Anatomic Graduated Component (Biomet, Warsaw, IN) TKA and elucidate the etiology and cause of failure of the components. METHODS: We reviewed the outcomes of 5649 primary total knee arthroplasties for 25-30 years using the Anatomic Graduated Component. Statistical analysis was performed by the Kaplan-Meier survival analysis. Clinical outcomes included the Knee Society Score and standardized radiographs to check for loosening of the implants. The reason for revision surgery was reviewed retrospectively. We compared our results with those at another institution with similar long-term follow-up. RESULTS: There were 112 failures, 48 with aseptic loosening and 25 with instability for an overall prosthesis survival rate of 94.2% at 25 years and 92.4% at 30 years follow-up. In the third decade after TKA, patients are substantially more likely to experience death than experience a failing prosthesis, with a 3811% greater risk of dying relative to failing (Risk ratio = 38.1, Odds ratio = 56.7, P < .0001). CONCLUSION: There was a greater risk of dying than failing over time. The primary reason for revision knee surgery was due to aseptic loosening of the prosthesis followed by instability.


Subject(s)
Arthroplasty, Replacement, Knee , Knee Prosthesis/statistics & numerical data , Prosthesis Failure , Aged , Aged, 80 and over , Female , Humans , Kaplan-Meier Estimate , Knee Joint/diagnostic imaging , Knee Joint/surgery , Male , Middle Aged , Radiography , Reoperation , Retrospective Studies , Time Factors
6.
Breast Cancer Res Treat ; 157(1): 1-11, 2016 05.
Article in English | MEDLINE | ID: mdl-27097608

ABSTRACT

One of the cancer molecular hallmarks is a deviant energetic metabolism, known as the Warburg effect, whereby the rate of glucose uptake is significantly increased and a high rate of glycolysis and lactic acid production occurs even when oxygen is present-"aerobic lactatogenesis". Accordingly, GLUT1 and MCT1, which are the main glucose and lactate transporters in cancer cells, respectively, have been proposed as oncogenes and are currently seen as potential therapeutic targets in cancer treatment. Polyphenols, commonly contained in fruits and vegetables, have long been associated with a protective role against cancer. Generally considered as nontoxic, dietary polyphenols are considered ideal chemopreventive and possibly chemotherapeutic agents. Several mechanisms of action of polyphenols in breast cancer cells have been proposed including modulation of intracellular signaling, induction of apoptosis through redox regulation or modulation of epigenetic alterations. Additionally, in vitro studies have shown that several polyphenols act as specific inhibitors of glucose transport in breast cancer cell lines and an association between their anticarcinogenic effect and inhibition of glucose cellular uptake has been described. Also, some polyphenols were found to inhibit lactate transport. Importantly, some polyphenols behave as inhibitors of both glucose and lactate cellular uptake by breast cancer cells and these compounds are thus very interesting in the context of a chemopreventive effect, because they deplete breast cancer cells of their two most important energy suppliers. So, the antimetabolic effect of polyphenols should be regarded as a mechanism of action contributing to their chemopreventive/chemotherapeutic potential in relation to breast cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Breast Neoplasms/metabolism , Glucose/metabolism , Lactic Acid/metabolism , Polyphenols/pharmacology , Antineoplastic Agents/therapeutic use , Biological Transport/drug effects , Breast Neoplasms/drug therapy , Breast Neoplasms/prevention & control , Cell Line, Tumor , Female , Gene Expression Regulation, Neoplastic/drug effects , Glucose Transporter Type 1/metabolism , Humans , Monocarboxylic Acid Transporters/metabolism , Polyphenols/therapeutic use , Symporters/metabolism
7.
J Arthroplasty ; 30(1): 86-9, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25151092

ABSTRACT

The purpose of this study was to investigate the use for screws and cement, and primary and revision specific prosthesis for revision TKA. Between July 1989 and February 2010, 839 consecutive revision TKAs were performed, with 609 knees meeting inclusion criteria. At 17 years followup, Kaplan-Meier survivorship was 0.9859 for revision specific prosthesis with screws and cement, 0.9848 for revision prosthesis with no screws, 0.9118 for primary prosthesis with screws, and 0.9424 for primary prosthesis with no screws. Revision TKAs using screws had greater defects (P<.0001). Use of revision prosthesis along with screws and cement to correct largely defective revision TKAs is highly recommended.


Subject(s)
Arthroplasty, Replacement, Knee , Knee Prosthesis , Adult , Aged , Aged, 80 and over , Bone Cements , Bone Screws , Cementation , Female , Follow-Up Studies , Humans , Knee Joint/surgery , Male , Middle Aged , Prosthesis Design , Prosthesis Failure , Reoperation , Retrospective Studies , Tibia/surgery
8.
Mol Cell Endocrinol ; 399: 386-94, 2015 Jan 05.
Article in English | MEDLINE | ID: mdl-25199616

ABSTRACT

A balanced cytotrophoblast cell turnover is crucial for placental development and anomalies in this process associated with gestational diseases. The endocannabinoid system (ECS) has emerged as a new player in several biological processes. However, its influence during placental development is still unknown. We report here the expression of the endocannabinoid 2-arachidonoylglycerol (2-AG) main metabolic enzymes in human cytotrophoblasts and syncytiotrophoblast. We also showed that 2-AG induced a decrease in placental alkaline phosphatase activity, human chorionic gonadotropin secretion and Leptin mRNA levels. Moreover, 2-AG reduced glial cell missing 1 and syncytin-2 transcription and the number of nuclei in syncytium. These effects were mediated by cannabinoid receptors and may result from 2-AG inhibition of the cAMP/PKA signalling pathway. Our data suggest that 2-AG may interfere with the biochemical and morphological differentiation of human cytotrophoblasts, through a CB receptor-dependent mechanism, shedding light on a role for the ECS in placental development.


Subject(s)
Arachidonic Acids/metabolism , Endocannabinoids/metabolism , Giant Cells/metabolism , Glycerides/metabolism , Signal Transduction/physiology , Trophoblasts/metabolism , Adult , Alkaline Phosphatase/metabolism , Chorionic Gonadotropin/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Female , Giant Cells/cytology , Humans , Leptin/metabolism , Pregnancy , Pregnancy Proteins/metabolism , Trophoblasts/cytology
9.
Clin Orthop Relat Res ; 473(2): 543-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24993142

ABSTRACT

BACKGROUND: Uncemented stems have been used in THA for well over two decades, but there are relatively few studies reporting on the results after 20 years. QUESTIONS/PURPOSES: The purpose of this study was to evaluate at a minimum followup of 20 years (1) hip scores; (2) radiographic findings, including stem fixation and osteolysis; (3) reoperations; and (4) survivorship free from aseptic loosening in a group of patients who underwent primary THA using a proximally porous-coated, plasma-sprayed, straight-stemmed, titanium-alloy femoral component. METHODS: Between 1987 and 1993, we performed 1517 primary THAs, of which 447 were cementless, and 157 used the implant under study here (representing 10% of the THAs during the period in question). General indications for the use of the study stem included (1) younger age with relatively stronger bone (average age 55 years in this study); (2) patients not involved in another study protocol (as were the 278 other cementless hips implanted during this time); and (3) patients who, at the surgeon's discretion, would be compliant with protected weightbearing. Of those, 111 were available for followup at a minimum of 20 years (mean, 20 years), whereas 36 had died and nine (6%) were lost to followup or declined participation. The primary diagnosis was osteoarthritis in 77 hips (69%). The mean age at operation was 55 years. The clinical result was evaluated on the basis of the Harris hip score. Radiographic analysis was performed at each followup visit for distal cortical hypertrophy, spot welds, radiolucencies, stem subsidence, varus or valgus shift, osteolysis, and femoral component loosening. Kaplan-Meier analysis was performed to evaluate the survival of the femoral component. RESULTS: The mean Harris hip score improved from 46 points to 87 points (of a possible 100 points) at the most recent followup. All hips had evidence of proximal femoral remodeling consistent with osseous ingrowth. Femoral osteolyis was seen in 22 hips (20%). One stem was revised as a result of a periprosthetic fracture. No femoral component had evidence of loosening, and none was revised. Thirty-three acetabular components (30%) were revised. CONCLUSIONS: This femoral component provided durable long-term fixation for over two decades after THA. The porous stem geometry is still in use today and will continue to be studied into the third decade of use. LEVEL OF EVIDENCE: Level IV, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.


Subject(s)
Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Hip/methods , Cementation , Female , Femur Head Necrosis/surgery , Follow-Up Studies , Humans , Male , Middle Aged , Reoperation , Treatment Outcome
10.
Int J Biochem Cell Biol ; 57: 177-85, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25450464

ABSTRACT

The normal development of placenta relies essentially on a balanced proliferation, differentiation and apoptosis of cytotrophoblasts. These processes are tightly regulated by several hormones, cytokines, lipids and other molecules and anomalies in these events are associated with gestational complications. The cation channel transient receptor potential vanilloid 1 (TRPV1) is expressed in several organs and tissues and it participates in cellular events like nociception, inflammation and cell death. However, the expression and importance of this receptor in human placenta still remains unknown. In this work, we found that TRPV1 is expressed in human cytotrophoblasts and syncytiotrophoblasts. Furthermore, the TRPV1 agonists capsaicin and anandamide decreased cytotrophoblast viability and induced morphological alterations, such as chromatin condensation and fragmentation, which suggest the occurrence of apoptosis. Also, both TRPV1 agonists induced a loss of mitochondrial membrane potential and an increase of caspase 3/7 activity and production of reactive species of oxygen and nitrogen. Furthermore, capsaicin (10 µM) impaired the spontaneous in vitro differentiation of cytotrophoblasts into syncytiotrophoblasts by triggering TRPV1, as observed by the decrease in placental alkaline phosphatase activity and in human chorionic gonadotropin secretion. On the other hand, anandamide decreased placental alkaline phosphatase activity via a TRPV1-independent mechanism but did not influence the secretion of human chorionic gonadotropin. In conclusion, we showed that TRPV1 is expressed in human cytotrophoblasts and syncytiotrophoblasts and also reported the involvement of this receptor in cytotrophoblast apoptosis and differentiation.


Subject(s)
TRPV Cation Channels/biosynthesis , Trophoblasts/metabolism , Apoptosis/physiology , Arachidonic Acids/pharmacology , Calcium Channel Blockers/pharmacology , Capsaicin/pharmacology , Cell Differentiation/physiology , Cell Survival/drug effects , Endocannabinoids/pharmacology , Female , Humans , Polyunsaturated Alkamides/pharmacology , Pregnancy , TRPV Cation Channels/agonists , Trophoblasts/drug effects
11.
HSS J ; 10(2): 107-15, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25050092

ABSTRACT

BACKGROUND: The orthopedic literature has not shown a universal and replicated difference, outside of flexion, in clinical results between posterior cruciate ligament retention and posterior cruciate ligament substitution in total knee arthroplasty. QUESTIONS/PURPOSES: This study was performed to compare the restoration of flexion and knee function in a large series of cruciate-retaining and cruciate-substituting total knee arthroplasties (TKRs). In addition, we aimed to study how other variables, such as those unique to each surgeon, may have affected the results. PATIENTS AND METHODS: The current study evaluated 8,607 total knee arthroplasties in 5,594 patients performed by six surgeons, each using one of four prosthesis designs (two posterior cruciate ligament retaining, two posterior cruciate ligament substituting). Knees were compared at the level of cruciate-retaining and cruciate-substituting knees, at the level of the four prostheses, and at the level of surgeon-implant combinations. Least squared means scores were obtained through multiple linear regression, analysis of variance, and the maximum likelihood method. RESULTS: At the level of posterior cruciate ligament treatment, posterior cruciate ligament substitution as a whole showed 3.2° greater flexion than posterior cruciate ligament retention. At the prosthesis level, cruciate-substituting models provided greater flexion and cruciate-retaining models provided higher function scores. In the surgeon-implant combinations, surgeons provided mixed results that often did not reflect findings from other levels; one surgeon's use of a posterior cruciate ligament retaining prosthesis achieved 14.7° greater flexion than the surgeon's use of a corresponding posterior cruciate ligament substituting design. CONCLUSIONS: Posterior cruciate ligament treatment is confounded by other variables, including the operating surgeon. The arthroplasty surgeon should choose a prosthesis based, not only on outside results, but also on personal experience and comfort.

12.
J Arthroplasty ; 29(6): 1207-10, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24456788

ABSTRACT

The purpose of this study was to investigate screws and cement for large tibial bone defects during primary TKA. Of 14,686 consecutive primary TKAs performed between December 1988 and February 2010, 256 received screws and cement for tibial defects. Cox regression was used for the analysis. 20-year survival probability was 0.9897 (screws) and 0.9339 (no screws) (P = .4225 log-rank). Tibial bone condition was significantly worse in knees receiving screws (P < .0001) with 73.0% having defects in the screws group and 3.4% (P < .0001) for non-screws. Radiolucency appeared in 13.7% (screws) and 6.4% (no screws) postoperatively. Screws were $137 each, wedges $910 to $2240. Knees with tibial defects and screws performed similarly if not better than knees without defects at substantially lower cost than alternatives.


Subject(s)
Arthritis/surgery , Arthroplasty, Replacement, Knee , Tibia/surgery , Bone Cements , Bone Resorption/surgery , Bone Screws , Follow-Up Studies , Humans , Knee Joint/surgery , Radiography , Tibia/diagnostic imaging
13.
Reproduction ; 147(3): 301-11, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24324206

ABSTRACT

The major endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG) is a member of the endocannabinoid system (ECS) that participates in cell proliferation and apoptosis, important events for the homoeostasis of biological systems. The formation of placenta is one of the most important stages of pregnancy and its development requires highly regulated proliferation, differentiation and apoptosis of trophoblasts. Anomalies in these processes are associated with gestational pathologies. In this work, we aimed to study the involvement of 2-AG in cytotrophoblast cell turnover. We found that 2-AG biosynthetic (diacylglycerol lipase A) and degradative (monoacylglycerol lipase) enzymes are expressed in human cytotrophoblasts and in BeWo cells. We also found that 2-AG induces a decrease in cell viability in a time- and concentration-dependent manner and exerts antiproliferative effects. The loss of cell viability induced by a 48-h treatment with 2-AG (10 µM) was accompanied by chromatin fragmentation and condensation, morphological features of apoptosis. Additionally, 2-AG induced an increase in caspase 3/7 and 9 activities, a loss of mitochondrial membrane potential (Δψm) and an increase in reactive oxygen species (ROS)/reactive nitrogen species (RNS) generation, suggesting the activation of the mitochondrial pathway. Moreover, whereas Δψm loss and ROS/RNS generation were significantly attenuated by the antagonists of both the cannabinoid receptors 1 and 2 (CB1 and CB2), the increase in caspase 3/7 and 9 activities and loss of cell viability were reversed only by the antagonist of CB2 receptor; the blockage of the eCB membrane transporter and the depletion of cholesterol failed to reverse the effects of 2-AG. Therefore, this work supports the importance of cannabinoid signalling during cytotrophoblast cell turnover and that its deregulation may be responsible for altered placental development and poor pregnancy outcomes.


Subject(s)
Apoptosis/drug effects , Arachidonic Acids/pharmacology , Endocannabinoids/pharmacology , Glycerides/pharmacology , Lipoprotein Lipase/genetics , Monoacylglycerol Lipases/genetics , Trophoblasts/drug effects , Apoptosis/genetics , Arachidonic Acids/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , Endocannabinoids/metabolism , Female , Gene Expression Regulation, Enzymologic/drug effects , Glycerides/metabolism , Humans , Lipoprotein Lipase/metabolism , Metabolic Networks and Pathways/genetics , Monoacylglycerol Lipases/metabolism , Pregnancy , Receptor, Cannabinoid, CB1/physiology , Receptor, Cannabinoid, CB2/physiology , Trophoblasts/physiology
14.
Orthop Traumatol Surg Res ; 99(8): 903-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24184203

ABSTRACT

INTRODUCTION: Conservative treatment is exceptional in fracture of the distal extremity of the humerus in patients over 65 years of age. In a selected population, however, it may be an attractive option. MATERIALS AND METHODS: One prospective and one retrospective study included a total of 56 patients, with a mean age of 84.7 years (range, 68-100 yrs). All were managed by 6 to 8 weeks' brachial-antebrachial-palmar immobilization, without fracture reduction. Fractures were AO type A in 18 cases, type B in 8 cases and type C in 30 cases. RESULTS: At a mean 20.2 months' follow-up in the retrospective and 8.6 months in the prospective series, mean MEPS score was 83 and 86 points with 75% and 83% satisfactory results respectively and mean Quick-DASH 31.3 and 34.4 points respectively. There were 3 non-unions. There was extra-articular malunion in 70% and intra-articular malunion in 65% of cases in the retrospective series, versus 16% intra-articular malunion in the prospective series. The rate of osteoarthritis increased over time, with more than 50% grade 2 or 3 in the retrospective series at end of follow-up. There were 3 complications: 2 hematomas and 1 skin lesion (localized pressure ulcer). There were 3 fracture displacements, not requiring change in management. DISCUSSION: Conservative treatment for fracture of the distal extremity of the humerus in patients over 65 years of age is exceptional, but conserves patient's independence and provides satisfactory clinical results, with no significant joint stiffness or elbow instability. Non-anatomic results on X-ray, however, have to be accepted.


Subject(s)
Casts, Surgical , Elbow Injuries , Fracture Fixation , Humeral Fractures/surgery , Intra-Articular Fractures/surgery , Aged , Aged, 80 and over , Elbow Joint/diagnostic imaging , Elbow Joint/surgery , Female , Fracture Fixation, Internal , Fractures, Malunited/epidemiology , Fractures, Malunited/surgery , Humans , Humeral Fractures/diagnostic imaging , Immobilization , Intra-Articular Fractures/diagnostic imaging , Male , Prospective Studies , Radiography , Retrospective Studies
15.
Placenta ; 34(11): 1095-8, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24054539

ABSTRACT

We aimed to determine the oxidative stress status in placentas obtained from gestational (GDM) and type 1 (T1D) diabetic pregnancies. Malonaldehyde and protein carbonyls, two biomarkers of oxidative damage, were higher in T1D but not in GDM placentas. Also, higher reduced glutathione and lower oxidized glutathione levels and higher glutathione peroxidase activity were found in T1D but not in GDM placentas. These results suggest that T1D placentas may develop a protective antioxidant mechanism to overcome higher oxidative stress levels.


Subject(s)
Diabetes Mellitus, Type 1/metabolism , Glutathione Peroxidase/metabolism , Glutathione/metabolism , Oxidative Stress , Placenta/metabolism , Pregnancy in Diabetics/metabolism , Up-Regulation , Adult , Biomarkers/metabolism , Diabetes Mellitus, Type 1/enzymology , Diabetes, Gestational/enzymology , Diabetes, Gestational/metabolism , Drug Resistance , Female , Humans , Malondialdehyde/metabolism , Oxidants/pharmacology , Oxidation-Reduction , Oxidative Stress/drug effects , Placenta/drug effects , Placenta/enzymology , Pregnancy , Pregnancy in Diabetics/enzymology , Protein Carbonylation/drug effects , Term Birth , Up-Regulation/drug effects , tert-Butylhydroperoxide/pharmacology , Glutathione Peroxidase GPX1
16.
Clin Orthop Relat Res ; 470(1): 144-9, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21984354

ABSTRACT

BACKGROUND: TKA provides demonstrable pain relief and improved health-related quality of life. Yet, a decline in physical function may occur over the long term despite the absence of implant-related problems. QUESTIONS/PURPOSES: (1) Does pain relief diminish over 20 years after TKA? (2) Does function decline over 20 years in terms of Knee Society function, knee, and walking scores? And (3) what is the patient-reported activity level at most recent followup? PATIENTS AND METHODS: We retrospectively identified 1471 patients with 1757 primary cruciate-retaining TKAs implanted between 1975 and 1989 and identified 128 living patients (8.7%) with 171 TKAs. Ninety-three patients were women. We determined Knee Society scores prospectively and UCLA scores retrospectively. Minimum followup was 20 years (average, 21.1 years; range, 20-27 years). Average age at last followup was 82.3 years (range, 45-103 years). Of the 128 patients, 66 (73 TKAs) died after 20-year followup. RESULTS: Pain scores did not diminish over time (average, 49; range, 20-50). Average knee score was 78 (range, 39-97). Function, stair, and walking scores diminished over time. Average function score was 70 (range, 5-100), primarily due to an average stair score of 35 (range, 0-50); average walking score was 37 (range, 10-50). All but two patients (two TKAs) could negotiate stairs; 95 patients (124 TKAs) could walk at least five blocks; three patients (three TKAs) were housebound. Of the 62 patients still living (98 TKAs), the average UCLA activity score was 8.3 (range, 5-10). CONCLUSIONS: Although aging may cause a gradual decline in physical activity, an improved functional capacity and activity level continue 20 years or more after TKA.


Subject(s)
Aging/physiology , Arthroplasty, Replacement, Knee/methods , Pain Measurement , Physical Fitness/physiology , Quality of Life , Range of Motion, Articular/physiology , Aged , Aged, 80 and over , Analysis of Variance , Arthroplasty, Replacement, Knee/adverse effects , Cohort Studies , Female , Follow-Up Studies , Humans , Knee Prosthesis , Male , Middle Aged , Recovery of Function , Retrospective Studies , Risk Assessment , Time Factors , Treatment Outcome
17.
Clin Orthop Relat Res ; 470(2): 388-94, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21932102

ABSTRACT

BACKGROUND: Large-diameter metal-on-metal articulations reportedly improve stability and wear in THAs. However, some reports suggest some patients have unexplained hip and early failures with these implants. Thus, the potential benefits may be offset by these concerns. However, the incidence of these problems is not clearly established. QUESTIONS/PURPOSES: We therefore assessed hip pain, function, osteolysis, and complications in patients with large-diameter metal-on-metal THA. PATIENTS AND METHODS: We retrospectively reviewed 611 patients who had 681 large-diameter metal-on-metal THAs with the same cup and head design. The average age at operation was 62 years, 53% of the THAs were in men, and the average body mass index was 32 kg/m(2). The diagnosis was osteoarthritis in 92% of the THAs. The minimum followup was 24 months (mean, 37 months; range, 24-60 months). RESULTS: Nine of the 611 patients (1.5%) experienced moderate or severe pain in the hip region that we considered to be coming from an extraarticular source in each case. Harris hip scores for pain averaged 42 points. Total Harris hip scores averaged 93 points. Cup abduction averaged 42°, and cup anteversion averaged 26°. There were no infections. Three cups (0.4%) were considered radiographically loose. All were secondary to inadequate seating of the shell. CONCLUSION: Our observations suggest with this implant the concerns of higher incidences of groin pain, early failures, and adverse tissue reactions were not confirmed. Early successes or failures with large-diameter metal-on-metal articulations may be implant specific. LEVEL OF EVIDENCE: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.


Subject(s)
Arthralgia/etiology , Arthroplasty, Replacement, Knee/adverse effects , Arthroplasty, Replacement, Knee/instrumentation , Hip Joint/surgery , Hip Prosthesis , Metals , Pain, Postoperative/etiology , Prosthesis Failure , Adult , Aged , Aged, 80 and over , Female , Groin , Hip Joint/physiopathology , Humans , Incidence , Indiana , Male , Middle Aged , Osteolysis/etiology , Osteolysis/prevention & control , Pain Measurement , Prosthesis Design , Recovery of Function , Retrospective Studies , Time Factors , Treatment Outcome
18.
IEEE Trans Vis Comput Graph ; 18(12): 2088-94, 2012 Dec.
Article in English | MEDLINE | ID: mdl-26357115

ABSTRACT

The U.S. Department of Energy's (DOE) Office of Environmental Management (DOE/EM) currently supports an effort to understand and predict the fate of nuclear contaminants and their transport in natural and engineered systems. Geologists, hydrologists, physicists and computer scientists are working together to create models of existing nuclear waste sites, to simulate their behavior and to extrapolate it into the future. We use visualization as an integral part in each step of this process. In the first step, visualization is used to verify model setup and to estimate critical parameters. High-performance computing simulations of contaminant transport produces massive amounts of data, which is then analyzed using visualization software specifically designed for parallel processing of large amounts of structured and unstructured data. Finally, simulation results are validated by comparing simulation results to measured current and historical field data. We describe in this article how visual analysis is used as an integral part of the decision-making process in the planning of ongoing and future treatment options for the contaminated nuclear waste sites. Lessons learned from visually analyzing our large-scale simulation runs will also have an impact on deciding on treatment measures for other contaminated sites.

19.
Ann Trop Paediatr ; 31(4): 287-95, 2011.
Article in English | MEDLINE | ID: mdl-22041462

ABSTRACT

The Millennium Development Goals are a set of eight goals drafted by the United Nations in 2000 with the aim of improving the health and welfare of people worldwide. The goals provide specific targets to be met by 2015, using the 1990 basis as a standard. This review presents these goals as they relate to children, discussing progress and future aims. Although not all eight goals specifically address children, each has its own impact on global child health. Thus far, much progress has been made, but increased rates of improvement must be achieved in order to meet the goals by 2015 and improve the health of children worldwide.


Subject(s)
Child Welfare , Global Health , Adolescent , Child , Child, Preschool , Goals , Health Policy , Humans , Infant , Infant, Newborn , United Nations
20.
Clin Orthop Relat Res ; 469(2): 405-11, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20852973

ABSTRACT

BACKGROUND: Polyethylene wear may be affected by the type of polyethylene resin, manufacturing technique, degree of thermal stabilization, and sterilization technique. QUESTIONS/PURPOSES: We therefore compared femoral head penetration into the PE and cup survival using the same cup system with different PE resins, manufacturing, and sterilization techniques. METHODS: Our study group consisted of 1912 THAs performed using the same uncemented cup and identical 28-mm cobalt-chrome heads. The polyethylene varied as follows: Group 1 (94 cups), GUR 4150 resin, ram-extruded, sterilized in air, no barrier packaging; Group 2 (74 cups), same as Group 1 but sterilized in argon; Group 3 (75 cups), Himont 1900 resin, compression-molded bar stock, sterilized in argon, no barrier packaging; Group 4 (620 cups), same as Group 3 except with barrier packing; Group 5 (711 cups), GUR 1050 resin, compression-molded bar stock, sterilized in argon gas with barrier packaging; and Group 6 (338 cups), GUR 1050 resin, compression-molded bar stock, sterilized in argon with barrier packaging, irradiated with 50 kGy, heated below melting temperature, machined, and finally placed in nonbarrier packaging with gas plasma sterilization. Minimum followup was 2 years (average, 7 years; range, 2-17 years). RESULTS: Femoral head penetration averaged 0.05 mm per year for Groups 5 and 6 and was substantially lower than for Groups 1 to 4. Cup survival was higher at seven years in Groups 3, 4, and 5, and at 10 years in group 4 when compared to groups 1, 2, and 3. CONCLUSIONS: We observed lower FHP rates and higher cup survival with polyethylene machined from direct compression-molded bar stock, sterilized in argon gas, with barrier packaging. LEVEL OF EVIDENCE: Level III Therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.


Subject(s)
Acetabulum/surgery , Arthroplasty, Replacement, Hip/instrumentation , Biocompatible Materials , Hip Prosthesis , Materials Testing/methods , Polyethylenes , Adolescent , Adult , Aged , Aged, 80 and over , Arthroplasty, Replacement, Hip/methods , Biomechanical Phenomena , Female , Femur Head/diagnostic imaging , Femur Head/pathology , Humans , Joint Diseases/surgery , Male , Middle Aged , Prosthesis Failure , Radiography , Surface Properties , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...